SHANGHAI – AstraZeneca’s (NASDAQ: AZN) blockbuster breast cancer drug Enhertu will be added to China’s state-run health insurance scheme from
1 year ago
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
More than 200,000 prescriptions for copies of Novo Nordisk’s (NYSE: NVO) weight-loss drug Wegovy are getting filled by U.S. patients
On Monday, Merck (NYSE: MRK) said its drug, Winrevair, helped significantly reduce the risk of death in patients with a
Halozyme Therapeutics (NASDAQ: HALO) has pulled its proposal to buy Evotec SE (NASDAQ: EVO) for 2 billion euros ($2.09 billion)
Sanofi (NASDAQ: SNY), the French drugmaker, plans to change its policy on how it gives discounts to certain U.S. hospitals
BRUSSELS/LONDON – Novo Holdings is set to gain unconditional EU antitrust approval for its planned $16.5 billion takeover of U.S.
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co (NYSE: MRK) may
Britain’s competition watchdog fined U.S. firm Viatris (NASDAQ: VTRS) 1.5 million pounds ($1.88 million) on Friday for violating an order
FRANKFURT – Novartis (NYSE: NVS) raised its medium-term sales guidance on Thursday to 6% annual growth through 2028, driven by
ROME – Cinven, the private equity firm, secured conditional approval from Italian authorities over its plan to sell a 15%
NEW YORK – About 44% of U.S. employers with 500 or more employees cover drugs for weight loss in 2024,
